February 10th, 2022
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
February 10th, 2022
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
July 22nd, 2020
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
April 9th, 2020
New formulations enable oral delivery of therapeutics traditionally delivered intravenously
March 8th, 2019
Early-stage drug-delivery projects become business plans at OTD’s Guppy Tank
October 3rd, 2018
In exploring the action of microvesicles, Quan Lu and colleagues at Harvard Chan School are mapping the next frontier of medical diagnostics and drug delivery